OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mechanisms of nanoparticle delivery to solid tumours
Luan N. Nguyen, Wayne Ngo, Zachary P. Lin, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 3, pp. 201-213
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Designing nanozymes for in vivo applications
Ruofei Zhang, Bing Jiang, Kelong Fan, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 10, pp. 849-868
Closed Access | Times Cited: 54

Immunogenicity of Extracellular Vesicles
Yutian Xia, Jianzhong Zhang, Gang Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 33
Open Access | Times Cited: 38

Rational Design of Dual-Targeted Nanomedicines for Enhanced Vascular Permeability in Low-Permeability Tumors
Mingsheng Zhu, Qiqi Liu, Zhengbang Chen, et al.
ACS Nano (2025)
Closed Access | Times Cited: 3

Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
Anshuman Dasgupta, Alexandros Marios Sofias, Fabian Kießling, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 9, pp. 714-716
Closed Access | Times Cited: 15

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review
Xuan Meng, Yongli Shen, Huanyu Zhao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14

Nanoparticle innovations in targeted cancer therapy: advancements in antibody–drug conjugates
Magdi T. Abdelhamid, Al-Hassan Soliman Wadan, Hosam A. Saad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1

In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology
Julie Schock Vaiani, Mans Broekgaarden, Jean‐Luc Coll, et al.
Nanoscale (2025)
Closed Access | Times Cited: 1

Design of oxide nanoparticles for biomedical applications
Bowon Lee, Yun‐Jung Lee, Jeong Yong Lee, et al.
Nature Reviews Materials (2025)
Closed Access | Times Cited: 1

Innovative landscapes in intraperitoneal therapy of ovarian cancer
K. Kumar, M. S. Madhusoodanan, Meghna Pangath, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 1

Learning lessons from nano-medicine to improve the design and performances of nano-agrochemicals
Vu Thanh Cong, J. Justin Gooding, Mélanie Kah
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

The pathways for nanoparticle transport across tumour endothelium
Jamie L. Y. Wu, Qin Ji, Colin Blackadar, et al.
Nature Nanotechnology (2025)
Closed Access | Times Cited: 1

Elucidation of Spatial Cooperativity in Chemo‐Immunotherapy by a Sequential Dual‐pH‐Responsive Drug Delivery System
Shihao Wang, Lifeng Liu, Limin Tian, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 7

Carrier-Free Nanodrugs: From Bench to Bedside
Fang Fang, Xiaoyuan Chen
ACS Nano (2024) Vol. 18, Iss. 35, pp. 23827-23841
Closed Access | Times Cited: 7

Comparison of passive targeted delivery of inorganic and organic nanocarriers among different types of tumors
Alisa S. Postovalova, Yulia A. Tishchenko, Maria S. Istomina, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 59, pp. 102753-102753
Closed Access | Times Cited: 6

Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application
Chong Gao, Jianping Jiang, Jing Zhao, et al.
Coordination Chemistry Reviews (2024) Vol. 519, pp. 216109-216109
Open Access | Times Cited: 6

Design and translation of injectable biomaterials
Michael Nguyen, Maria Karkanitsa, Karen L. Christman
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 10, pp. 810-828
Closed Access | Times Cited: 6

Emissive Lipid Nanoparticles as Biophotonic Contrast Agent for Site-Selective Solid Tumor Imaging in Pre-Clinical Models
Rajendra Prasad, Rohini Kumari, Ruchita Chaudhari, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 40, pp. 53393-53404
Closed Access | Times Cited: 5

Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors
Sara El‐Sahli, Shireesha Manturthi, Emma Durocher, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access

Gold nanocomposites in colorectal cancer therapy: characterization, selective cytotoxicity, and migration inhibition
K. Tan, Le Yi Chia, Marwan Abdelmahmoud Abdelkarim Maki, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Nanoparticle troopers: Infiltrating cancer cells for targeted therapies
Shivam Rajput, Rishabha Malviya, Sankha Bhattacharya, et al.
Nano-Structures & Nano-Objects (2025) Vol. 41, pp. 101453-101453
Closed Access

Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors
Anshuman Dasgupta, Jan‐Niklas May, Geir Klinkenberg, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 818-828
Open Access

Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors
Iaroslav B. Belyaev, Olga Yu. Griaznova, Alexey V. Yaremenko, et al.
Advanced Drug Delivery Reviews (2025), pp. 115550-115550
Open Access

Recent advances in nano-molybdenum oxide for photothermal cancer therapy
S Chen, Ping Zhang, Hongmei Bai, et al.
Nanomedicine (2025), pp. 1-19
Closed Access

Nanoparticles and Glycosaminoglycans: Progress and Applications for Cancer Therapy
Pietro Milesi, Annamaria Naggi, Francesca Baldelli Bombelli, et al.
Proteoglycan Research (2025) Vol. 3, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top